Onward Medical Statistics
Total Valuation
Onward Medical has a market cap or net worth of EUR 165.87 million. The enterprise value is 152.98 million.
Market Cap | 165.87M |
Enterprise Value | 152.98M |
Important Dates
The next estimated earnings date is Friday, September 27, 2024.
Earnings Date | Sep 27, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Onward Medical has 34.63 million shares outstanding. The number of shares has increased by 1.25% in one year.
Shares Outstanding | 34.63M |
Shares Change (YoY) | +1.25% |
Shares Change (QoQ) | +11.11% |
Owned by Insiders (%) | 8.43% |
Owned by Institutions (%) | 20.62% |
Float | 18.17M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 271.77 |
PB Ratio | 8.06 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -4.23 |
EV / Sales | 287.55 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -4.68 |
Financial Position
The company has a current ratio of 4.70, with a Debt / Equity ratio of 94.11.
Current Ratio | 4.70 |
Quick Ratio | 4.52 |
Debt / Equity | 94.11 |
Debt / EBITDA | n/a |
Debt / FCF | -0.52 |
Interest Coverage | -25.77 |
Financial Efficiency
Return on equity (ROE) is -102.55% and return on invested capital (ROIC) is -43.54%.
Return on Equity (ROE) | -102.55% |
Return on Assets (ROA) | -36.87% |
Return on Capital (ROIC) | -43.54% |
Revenue Per Employee | 5,374 |
Profits Per Employee | -365,465 |
Employee Count | 99 |
Asset Turnover | 0.01 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +5.74% in the last 52 weeks. The beta is 0.84, so Onward Medical's price volatility has been lower than the market average.
Beta (5Y) | 0.84 |
52-Week Price Change | +5.74% |
50-Day Moving Average | 4.96 |
200-Day Moving Average | 4.56 |
Relative Strength Index (RSI) | 44.76 |
Average Volume (20 Days) | 17,910 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Onward Medical had revenue of EUR 532,000 and -36.18 million in losses. Loss per share was -1.20.
Revenue | 532,000 |
Gross Profit | -14.82M |
Operating Income | -35.46M |
Pretax Income | -36.07M |
Net Income | -36.18M |
EBITDA | -35.23M |
EBIT | -35.46M |
Loss Per Share | -1.20 |
Balance Sheet
The company has 29.77 million in cash and 16.87 million in debt, giving a net cash position of 12.89 million or 0.37 per share.
Cash & Cash Equivalents | 29.77M |
Total Debt | 16.87M |
Net Cash | 12.89M |
Net Cash Per Share | 0.37 |
Equity (Book Value) | 17.93M |
Book Value Per Share | 0.59 |
Working Capital | 24.74M |
Cash Flow
In the last 12 months, operating cash flow was -32.27 million and capital expenditures -422,000, giving a free cash flow of -32.69 million.
Operating Cash Flow | -32.27M |
Capital Expenditures | -422,000 |
Free Cash Flow | -32.69M |
FCF Per Share | -0.94 |
Margins
Gross Margin | n/a |
Operating Margin | -6,665.98% |
Pretax Margin | -6,780.83% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -6,145.11% |
Dividends & Yields
Onward Medical does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.25% |
Shareholder Yield | -1.25% |
Earnings Yield | -25.05% |
FCF Yield | -19.71% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |